A center focused on advancing leukemia treatment through collaborative research.
Official title: ECOG-ACRIN Integrated Leukemia Translational Science Center (LTSC)
Funded at Sloan-Kettering Inst Can Research · NIH-11250227 · Data updated 2026-11-12
The Leukemia Translational Science Center is working with a team of experts to find new and better treatments for leukemia, using the latest technology and research to help improve care for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sloan-Kettering Inst Can Research NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | March 1, 2025 |
| Project end | February 28, 2026 |
| Funding year | 2025 |
| Award (this year) | $535,627 |
| NIH project number | 3UG1CA233332-06S1 |
| Project ID | NIH-11250227 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals diagnosed with leukemia who are seeking innovative treatment options.
✕Less likely to help
Patients with conditions other than leukemia may not receive any benefit from this research.
What this research studies
The Leukemia Translational Science Center (LTSC) is designed to lead and coordinate innovative studies in leukemia, bringing together experts from various fields such as clinical investigation, laboratory science, and computational biology. By utilizing advanced genomic technologies and a comprehensive data warehouse, the LTSC aims to accelerate the development of high-quality clinical trials. This collaborative effort will involve both junior and senior researchers, fostering teamwork to explore new treatment avenues and improve patient outcomes. The center will also provide funding for pilot projects to support groundbreaking research initiatives.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments and improved outcomes for patients with leukemia.
How similar studies have gone: Previous research initiatives in leukemia have shown promise in utilizing collaborative and translational approaches, indicating a strong potential for success in this novel center.
Where this research is happening
-
Sloan-Kettering Inst Can Research
New York, United States Active
Researchers
- Principal investigator: Levine, Ross L — Sloan-Kettering Inst Can Research
- Study coordinator: Levine, Ross L
Related research
Other NIH-funded projects on the same topics.
-
Investigating a specific type of leukemia in children caused by genetic changes.
This study is looking at how certain proteins linked to leukemia affect kids and teens with high-risk blood cancers, and the researchers hope to find new ways to treat these conditions by learning more about how the disease works.
-
Caregiver-led mobile tool to support healthy habits for kids treated for ALL
A caregiver-directed mobile program helps children who were treated for acute lymphoblastic leukemia build healthier daily routines.
-
Targeting the SCP4 pathway in acute myeloid leukemia (AML)
Aims to uncover how the SCP4 signaling pathway drives AML and how it could be blocked to help patients.
-
Understanding TCRs in Leukemia to Improve Immunotherapies
A short, patient-friendly look at a project trying to map how immune cells recognize leukemia so future therapies can be better and safer for people with AML.
-
Targeted therapy for AML using DHODH inhibitors to boost differentiation and immune response
Aims to help adults with acute myeloid leukemia by using a special drug approach that makes cancer cells act more like normal blood cells and supports the immune system.
-
Genomics of childhood ALL across global populations
A wide-ranging study looks at how inherited genetics influence the risk of childhood acute lymphoblastic leukemia around the world.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.